CFH and age-related macular degeneration: The genetic underpinning of this innate dysregulation is well established, Complement-pathway variants—notably in CFH (e.g., Y402H) and C3—confer substantial AMD risk across multiple independent cohorts, implicating innate immune dysregulation in pathogenesis (104–106).